GPTHEALTH161.06

GPT Healthcare Limited

· Pharma & Health
₹ CrorePeersGKSLSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,322 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)35.8840.8843.0943.09
Receivable Days (DSO)22.1522.3415.6715.67
Payable Days (DPO)164.49161.02170.36164.01
Cash Conversion Cycle (days)-106.46-97.80-111.60-105.25
Working Capital Turnover135.7189.0248.2950.25
Asset Turnover1.161.061.021.02
Cash Conversion (CFO/Net Income)1.441.351.921.92
CFO/EBITDA0.780.810.960.96
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.